Variant report

Variant	esv3693063
Chromosome Location	chr10:61316344-61331087
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:82)
CpG islands
(count:61)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:82 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr10:61326099-61326150	LNCaP	prostate:	n/a	n/a
2	CTCF	chr10:61316700-61316850	GM12865	blood:	n/a	n/a
3	E2F4	chr10:61322638-61322792	MCF10A-Er-Src	breast:	n/a	n/a
4	E2F4	chr10:61321613-61321915	MCF10A-Er-Src	breast:	n/a	n/a
5	EP300	chr10:61320831-61322239	SK-N-SH	brain:	n/a	chr10:61321505-61321519
6	EP300	chr10:61321056-61321932	SK-N-SH_RA	brain:	n/a	chr10:61321505-61321519
7	EP300	chr10:61316772-61317902	SK-N-SH	brain:	n/a	chr10:61317700-61317714
8	EP300	chr10:61316726-61317212	SK-N-SH_RA	brain:	n/a	n/a
9	EP300	chr10:61321036-61321903	SK-N-SH_RA	brain:	n/a	chr10:61321505-61321519
10	EP300	chr10:61316612-61317374	SK-N-SH	brain:	n/a	n/a
11	EP300	chr10:61316712-61317233	SK-N-SH_RA	brain:	n/a	n/a
12	EP300	chr10:61321037-61322186	SK-N-SH	brain:	n/a	chr10:61321505-61321519
13	FOS	chr10:61321273-61321813	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr10:61321339-61321757	MCF10A-Er-Src	breast:	n/a	n/a
15	FOS	chr10:61321453-61321677	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr10:61321250-61321812	MCF10A-Er-Src	breast:	n/a	n/a
17	FOSL2	chr10:61321163-61322004	SK-N-SH	brain:	n/a	n/a
18	FOSL2	chr10:61320971-61322372	SK-N-SH	brain:	n/a	n/a
19	FOXM1	chr10:61320885-61322173	SK-N-SH	brain:	n/a	n/a
20	FOXP2	chr10:61316904-61317173	SK-N-MC	brain:	n/a	n/a
21	GATA2	chr10:61316921-61317250	SH-SY5Y	brain:	n/a	chr10:61317116-61317126
22	GATA3	chr10:61320511-61322359	SK-N-SH	brain:	n/a	n/a
23	GATA3	chr10:61316728-61317870	SK-N-SH	brain:	n/a	chr10:61317392-61317405 chr10:61317786-61317799 chr10:61317116-61317126
24	GATA3	chr10:61328174-61328215	SH-SY5Y	brain:	n/a	n/a
25	GATA3	chr10:61316607-61318009	SK-N-SH	brain:	n/a	chr10:61317392-61317405 chr10:61317786-61317799 chr10:61317116-61317126
26	GATA3	chr10:61320823-61322250	SK-N-SH	brain:	n/a	n/a
27	GTF2F1	chr10:61317089-61317209	H1-hESC	embryonic stem cell:	n/a	n/a
28	JUND	chr10:61316697-61317282	SK-N-SH	brain:	n/a	n/a
29	JUND	chr10:61321035-61322271	SK-N-SH	brain:	n/a	n/a
30	JUND	chr10:61321028-61322116	SK-N-SH	brain:	n/a	n/a
31	MAX	chr10:61321496-61322070	SK-N-SH	brain:	n/a	n/a
32	MAX	chr10:61323236-61323711	SK-N-SH	brain:	n/a	n/a
33	MAX	chr10:61321503-61322063	SK-N-SH	brain:	n/a	n/a
34	MAX	chr10:61316906-61317531	H1-hESC	embryonic stem cell:	n/a	chr10:61317058-61317067
35	MAZ	chr10:61320094-61320114	HepG2	liver:	n/a	n/a
36	MYC	chr10:61321258-61321702	MCF10A-Er-Src	breast:	n/a	n/a
37	NFIC	chr10:61320953-61322333	SK-N-SH	brain:	n/a	n/a
38	NFIC	chr10:61316756-61317291	SK-N-SH	brain:	n/a	n/a
39	NFIC	chr10:61321114-61321992	SK-N-SH	brain:	n/a	n/a
40	PBX3	chr10:61320930-61322141	SK-N-SH	brain:	n/a	chr10:61321260-61321269
41	PBX3	chr10:61316690-61317266	SK-N-SH	brain:	n/a	n/a
42	PBX3	chr10:61320695-61322396	SK-N-SH	brain:	n/a	chr10:61321260-61321269
43	PBX3	chr10:61316805-61317190	SK-N-SH	brain:	n/a	n/a
44	POLR2A	chr10:61325637-61325684	K562	blood:	n/a	n/a
45	POLR2A	chr10:61317045-61317176	K562	blood:	n/a	n/a
46	POLR2A	chr10:61316868-61317555	H1-neurons	neurons:	n/a	n/a
47	POLR2A	chr10:61316874-61317218	SK-N-MC	brain:	n/a	n/a
48	POLR2A	chr10:61321626-61321910	SK-N-SH	brain:	n/a	n/a
49	POLR2A	chr10:61321058-61322225	SK-N-SH	brain:	n/a	n/a
50	POLR2A	chr10:61323260-61323629	SK-N-SH	brain:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:61320994-61321044	AG09309	skin:	n/a
2	chr10:61320994-61321044	HRCEpiC	kidney:	n/a
3	chr10:61320994-61321044	T-47D	breast:	n/a
4	chr10:61320994-61321044	HL-60	blood:	n/a
5	chr10:61320994-61321044	RPTEC	kidney:	n/a
6	chr10:61320994-61321044	GM12878	blood:	n/a
7	chr10:61320994-61321044	SK-N-MC	brain:	n/a
8	chr10:61320994-61321044	HRE	kidney:	n/a
9	chr10:61320994-61321044	GM12892	blood:	n/a
10	chr10:61320994-61321044	PFSK-1	brain:	n/a
11	chr10:61320994-61321044	AG09319	gingival:	n/a
12	chr10:61320994-61321044	ECC-1	luminal epithelium:	n/a
13	chr10:61320994-61321044	HUVEC	blood vessel:	n/a
14	chr10:61320994-61321044	AG04449	skin:	fetal
15	chr10:61320994-61321044	PANC-1	pancreas:	n/a
16	chr10:61320994-61321044	BJ	skin:	n/a
17	chr10:61320994-61321044	CMK	blood:	n/a
18	chr10:61320994-61321044	A549	lung:	n/a
19	chr10:61320994-61321044	Hela-S3	cervix:	n/a
20	chr10:61320994-61321044	U87	brain:	n/a
21	chr10:61320994-61321044	AoSMC	blood vessel:	n/a
22	chr10:61320994-61321044	Caco-2	colon:	n/a
23	chr10:61320994-61321044	SAEC	small airway:	n/a
24	chr10:61320994-61321044	GM19239	blood:	n/a
25	chr10:61320994-61321044	HNPCEpiC	eye:	n/a
26	chr10:61320994-61321044	HEK293	kidney:	embryo
27	chr10:61320994-61321044	HCM	heart:	n/a
28	chr10:61320994-61321044	MCF10A-Er-Src	breast:	n/a
29	chr10:61320994-61321044	NB4	blood:	n/a
30	chr10:61320994-61321044	NHBE	bronchial:	n/a
31	chr10:61320994-61321044	Jurkat	blood:	n/a
32	chr10:61320994-61321044	HMEC	breast:	n/a
33	chr10:61320994-61321044	HepG2	liver:	n/a
34	chr10:61320994-61321044	HCF	heart:	n/a
35	chr10:61320994-61321044	BE2_C	brain:	n/a
36	chr10:61320994-61321044	NT2-D1	testis:	n/a
37	chr10:61320994-61321044	NH-A	brain:	n/a
38	chr10:61320994-61321044	MCF-7	breast:	n/a
39	chr10:61320994-61321044	NHDF-neo	bronchial:	n/a
40	chr10:61320994-61321044	GM12891	blood:	n/a
41	chr10:61320994-61321044	HIPEpiC	eye:	n/a
42	chr10:61320994-61321044	K562	blood:	n/a
43	chr10:61320994-61321044	IMR90	lung:	fetal
44	chr10:61320994-61321044	ovcar-3	ovarian:	n/a
45	chr10:61320994-61321044	SK-N-SH_RA	brain:	n/a
46	chr10:61320994-61321044	SK-N-SH	brain:	n/a
47	chr10:61320994-61321044	HRPEpiC	eye:	n/a
48	chr10:61320994-61321044	HEEpiC	esophagus:	n/a
49	chr10:61320994-61321044	AG10803	skin:	n/a
50	chr10:61320994-61321044	LNCaP	prostate:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:61316394..61318901-chr10:61319114..61321714,2	K562	blood:
2	chr10:61316394..61318901-chr10:61319114..61321714,2	K562	blood:

No data

Variant related genes	Relation type
MRPL50P4	TF binding region
MRPL50P4	CpG island

Extended variants
information (count: 367 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1579014	chr10:61316344-61316345	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs575478392	chr10:61316368-61316369	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs375427597	chr10:61316369-61316370	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs546356818	chr10:61316411-61316412	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs148353330	chr10:61316425-61316426	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs374766642	chr10:61316503-61316504	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs573299694	chr10:61316528-61316529	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs540337466	chr10:61316556-61316557	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs141504720	chr10:61316567-61316568	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs529262422	chr10:61316585-61316586	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs542187420	chr10:61316586-61316587	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs563573280	chr10:61316595-61316596	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs528166866	chr10:61316598-61316599	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs552336202	chr10:61316627-61316628	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs185895311	chr10:61316645-61316646	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs528211629	chr10:61316654-61316655	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs535143202	chr10:61316672-61316673	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs567757793	chr10:61316703-61316704	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs547826950	chr10:61316728-61316729	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs533043174	chr10:61316791-61316792	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs4578336	chr10:61316793-61316794	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs569191597	chr10:61316813-61316814	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs539707159	chr10:61316873-61316874	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs558350036	chr10:61316928-61316929	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs573308535	chr10:61316930-61316931	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs540728753	chr10:61316963-61316964	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs555889919	chr10:61316978-61316979	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs574131783	chr10:61316990-61316991	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs118029054	chr10:61316993-61316994	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs369682882	chr10:61317039-61317040	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs563611896	chr10:61317068-61317069	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs190323597	chr10:61317100-61317101	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs138349943	chr10:61317153-61317154	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs530437064	chr10:61317180-61317181	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs564310074	chr10:61317203-61317204	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs528233869	chr10:61317212-61317213	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs546335103	chr10:61317268-61317269	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs549020215	chr10:61317277-61317278	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs142841176	chr10:61317328-61317329	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs551426406	chr10:61317360-61317361	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs528891932	chr10:61317488-61317489	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs528241316	chr10:61317521-61317522	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs545722880	chr10:61317552-61317553	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs146075106	chr10:61317558-61317559	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs568482468	chr10:61317559-61317560	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs540126370	chr10:61317581-61317582	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs182882142	chr10:61317614-61317615	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs556398771	chr10:61317661-61317662	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs374971718	chr10:61317718-61317719	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs139998330	chr10:61317759-61317760	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Obesity	21956041	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Metanephric adenoma	20802469	CNVD
Autism	20841430	CNVD
Prostate cancer	16573809	CNVD
Schizophrenia	19329560	CNVD
Heart failure	18772530	CNVD
Heart failure	18854381	CNVD
Hyperglycemia	19060297	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Usher syndrome	20538994	CNVD
Glioblastoma multiforme	17002787	CNVD
Urothelial carcinoma	21177765	CNVD
abnormal development	18461090	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	20643615	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic myelogenous leukemia	20824076	CNVD
Papillary thyroid carcinoma	20824076	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	20164919	CNVD

Chromatin state (count:109 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:61313400-61317800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr10:61313600-61317000	Weak transcription	Brain Anterior Caudate	brain
3	chr10:61313600-61317000	Weak transcription	Brain Inferior Temporal Lobe	brain
4	chr10:61313600-61317400	Weak transcription	Colon Smooth Muscle	Colon
5	chr10:61313600-61320800	Weak transcription	Rectal Smooth Muscle	rectum
6	chr10:61313800-61317000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr10:61314000-61316600	Weak transcription	Cortex derived primary cultured neurospheres	brain
8	chr10:61314000-61317200	Weak transcription	Brain Substantia Nigra	brain
9	chr10:61314600-61317000	Weak transcription	Brain Angular Gyrus	brain
10	chr10:61314800-61317000	Weak transcription	Brain Cingulate Gyrus	brain
11	chr10:61314800-61317000	Weak transcription	Brain Hippocampus Middle	brain
12	chr10:61316000-61316400	Enhancers	H9 Cell Line	embryonic stem cell
13	chr10:61316000-61317200	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr10:61316000-61317200	Enhancers	iPS-20b Cell Line	embryonic stem cell
15	chr10:61316000-61318000	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr10:61316000-61318200	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr10:61316000-61318200	Enhancers	iPS-15b Cell Line	embryonic stem cell
18	chr10:61316000-61318400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr10:61316000-61318400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
20	chr10:61316000-61318600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr10:61316200-61316400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
22	chr10:61316200-61316600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
23	chr10:61316200-61317200	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr10:61316200-61318200	Enhancers	H1 Cell Line	embryonic stem cell
25	chr10:61316200-61318400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr10:61316200-61318600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr10:61316200-61321400	Enhancers	Fetal Lung	lung
28	chr10:61316400-61317400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
29	chr10:61316400-61317400	Weak transcription	H9 Cell Line	embryonic stem cell
30	chr10:61316400-61317400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr10:61316600-61317800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr10:61316600-61318200	Enhancers	Cortex derived primary cultured neurospheres	brain
33	chr10:61316800-61317400	Enhancers	Adipose Nuclei	Adipose
34	chr10:61316800-61318200	Enhancers	HUES64 Cell Line	embryonic stem cell
35	chr10:61317000-61317400	Enhancers	Brain Angular Gyrus	brain
36	chr10:61317000-61317600	Enhancers	Brain Germinal Matrix	brain
37	chr10:61317000-61317600	Enhancers	Brain Inferior Temporal Lobe	brain
38	chr10:61317000-61317600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
39	chr10:61317000-61317600	Enhancers	Fetal Muscle Leg	muscle
40	chr10:61317000-61317800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr10:61317000-61317800	Enhancers	Brain Anterior Caudate	brain
42	chr10:61317000-61317800	Enhancers	Brain Hippocampus Middle	brain
43	chr10:61317000-61317800	Enhancers	Fetal Kidney	kidney
44	chr10:61317000-61318000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr10:61317000-61318000	Enhancers	Brain Cingulate Gyrus	brain
46	chr10:61317000-61318200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr10:61317000-61318800	Enhancers	Fetal Heart	heart
48	chr10:61317200-61317400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
49	chr10:61317200-61317600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
50	chr10:61317200-61318000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links